Publications scientifiques

Dépistage du cancer du sein, vaccination anti-HPV, Cochrane, COVID-19

Tinari S, Riva C. Covid-19: Whatever happened to the Novavax vaccine? BMJ 2021;375:n2965. doi: 10.1136/bmj.n2965

Tinari S, Riva C. Donuts, drugs, booze, and guns: what governments are offering people to take Covid-19 vaccines. BMJ 2021;374:n1737. doi: 10.1136/bmj.n1737

Riva C, Spinosa JP. Has the HPV vaccine approval ushered in an era of over-prevention? 2020. Journal of Scientific Practice and Integrity.2(1).doi: 10.35122/001c.18180

Boussageon R, Riva C, Michal-Teitelbaum C, Spinosa JP. VIVIANE study of HPV vaccination. Lancet Infect Dis. 2019 Dec;19(12):1281-1282. doi: 10.1016/S1473-3099(19)30619-X.

Riva C, Tinari S, Spinosa JP. Lessons learnt on transparency, scientific process and publication ethics. The short story of a long journey to get into the public domain unpublished data, methodological flaws and bias of the Cochrane HPV vaccines review. BMJ Evid Based Med. 2018 Dec 6. doi: 10.1136/bmjebm-2018-111119.

Riva C, Tinari S. Mapping ghost management in medical research and public health. BMJ Evid Based Med. Vol 23, Suppl 2. Aug 2018 doi: 10.1136/bmjebm-2018-111070.105.

Spinosa JP, Riva C, Autier P, Nicot P, Junod B. Letter to editor response to A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer. 2014 Sep 15;120(18):2936-7. doi: 10.1002/cncr.28528.

Riva C, Biollaz J, Foucras P, Junod B, Nicot P, Spinosa JP. Effect of population-based screening on breast cancer mortality. Lancet. 2012 Apr 7;379(9823):1296; author reply 1298. doi: 10.1016/S0140-6736(12)60548-0.

Spinosa JP, Riva C, Biollaz J. Letter to the editor response to the article of Luisa Lina Villa HPV prophylactic vaccination: the first years and what to expect from now, in press. Cancer Lett. 2011 May 1;304(1):70. doi: 10.1016/j.canlet.2011.01.024.